Straits Times Index
3,330.01 -8.93 (-0.27%) S&P 500
5,354.03 +62.69 (+1.18%) Dow
38,807.33 +96.04 (+0.25%) Nasdaq
17,187.90 +330.86 (+1.96%) Bitcoin USD
71,134.37 +710.61 (+1.01%) CMC Crypto 200
1,517.11 +43.37 (+2.94%)
EW Aug 2024 110.000 put
- Zacks
BD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite
BD's (BDX) latest agreement is likely to unlock new future value-creation opportunities and expand its portfolio of smart connected care solutions.
- Business Wire
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
NEW YORK, June 05, 2024--Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve patients there were excellent clinical outcomes and valve durability irrespective of the patient’s annulus size or sex. These data were presented during the late-breaking clinical
- Simply Wall St.
Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
